LISSSD 2025 , ,
Presentations this author is a contributor to:
Setting the scene for Group A Streptococcus vaccine studies: The complete clinical spectrum of severe acute disease is present in Auckland, Aotearoa New Zealand (#117)
5:30 PM
Andrew Fox-Lewis
Poster Session 1
Invasive Group A Streptococcus (iGAS) surveillance gets the green light: a clear-cut microbiological specimen sterility framework for comprehensive and consistent laboratory surveillance. (#118)
5:30 PM
Andrew Fox-Lewis
Poster Session 1